GlassScriptPhysician profile
Ashley Carnegie
NPI 1427719376
$4,745.67
in general payments reported to CMS, 2019-2025
40 companies · $1,525 in 2025
The $1,525 reported for 2025 was more than what 91% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $935 · 2023: $1,415 · 2024: $872 · 2025: $1,525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,811.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,811.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $405.21 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $334.64 | 2022-2025 | Airsupra, Breztri, Farxiga |
| Glaxosmithkline, LLC. | $323.67 | 2023-2025 | Nucala, Trelegy Ellipta, Shingrix |
| Abbvie INC. | $273.09 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $272.70 | 2023-2024 | Xarelto |
| Mylan Specialty L.P. | $253.02 | 2023-2024 | Yupelri, Yupelri |
| Amgen INC. | $246.49 | 2022-2025 | Prolia, Evenity, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $209.66 | 2022-2023 | Ofev, Jardiance |
| Viatris Specialty LLC | $200.44 | 2025 | Yupelri |
| Pfizer INC. | $193.39 | 2022-2025 | |
| Bausch Health US, LLC | $189.71 | 2022-2025 | Aplenzin, Wellbutrin |
| Axsome Therapeutics, INC. | $176.53 | 2023-2025 | Auvelity, Sunosi |
| Biohaven Pharmaceutical Holding Company LTD. | $173.89 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $162.62 | 2024-2025 | Dupixent |
| Jazz Pharmaceuticals INC. | $135.47 | 2024 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $128.40 | 2022-2023 | Azstarys |
| Novo Nordisk INC | $124.45 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Grifols USA, LLC | $111.74 | 2022-2025 | Prolastin-C Liquid, Xembify |
| Corcept Therapeutics | $96.91 | 2025 | Korlym |
| Exact Sciences Corporation | $92.10 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astellas Pharma US INC | $73.77 | 2023 | Veozah |
| Avadel Cns Pharmaceuticals, LLC | $72.12 | 2025 | Lumryz |
| Merck Sharp & Dohme LLC | $56.54 | 2022-2024 | Verquvo, Capvaxive, Gardasil 9 |
| Lundbeck LLC | $53.24 | 2022 | |
| Idorsia Pharmaceuticals US INC | $39.96 | 2022-2023 | Quviviq |
| Genzyme Corporation | $39.20 | 2025 | |
| Xeris Pharmaceuticals, INC. | $36.69 | 2025 | Recorlev, Gvoke Hypopen |
| Tolmar, INC. | $34.79 | 2023-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $33.68 | 2022-2025 | Trintellix |
| Harmony Biosciences LLC | $31.89 | 2024 | |
| Insmed, INC. | $24.75 | 2025 | Brinsupri, Arikayce |
| Aimmune Therapeutics, INC. | $23.46 | 2024 | |
| Ibsa Pharma INC. | $19.21 | 2022 | |
| Verona Pharma, INC. | $17.46 | 2025 | Ohtuvayre |
| Seqirus USA INC | $16.22 | 2025 | Fluad, Flucelvax |
| Philips North America LLC | $14.60 | 2025 | Vest Therapy Und |
| Electromed, INC. | $14.24 | 2025 | Smartvest |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.83 | 2023 | Xifaxan |
| Kowa Pharmaceuticals America, INC. | $13.29 | 2023 | Seglentis, Livalo |
| Amarin Pharma, INC. | $12.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Carnegie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.